Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

83 results about "Polydioxanone" patented technology

Polydioxanone (PDO, PDS) or poly-p-dioxanone is a colorless, crystalline, biodegradable synthetic polymer.

Biodegradable polymer coils for intraluminal implants

InactiveUS6423085B1DilatorsOcculdersPoly-L-lactideVascular compartment
An endovascular cellular manipulation and inflammatory response are elicited from implantation in a vascular compartment or any intraluminal location of a separable coil comprised at least in part of at least one biocompatible and absorbable polymer or protein and growth factors. Typically a catheter associated with the separable coil is used to dispose the coil into a selected body lumen. The biocompatible and absorbable polymer or protein is thrombogenic. The coil further is comprised at least in part of a growth factor or more particularly a vascular endothelial growth factor, a basic fibroblast growth factor or other growth factors. The biocompatible and absorbable polymer is in the illustrated embodiment at least one polymer selected from the group consisting of polyglycolic acid, poly~glycolic acid poly-L-lactic acid copolymers, polycaprolactive, polyhydroxybutyrate / hydroxyvalerate copolymers, poly-L-lactide. Polydioxanone, polycarbonates, and polyanhydrides. The biocompatible and absorbable protein is at least one protein selected from the group consisting of collagen, fibrinogen, fibronectin, vitronectin, laminin, and gelatin. In one embodiment the coil is composed of the biocompatible and absorbable polymer or protein with a radio-opaque material is disposed thereon. Alternatively, the coil is composed of a radio-opaque material, and the biocompatible and absorbable polymer or protein is disposed thereon. This apparatus may be positioned within intracranial aneurysms or any aneurysm in the body as well as within other body cavities.
Owner:RGT UNIV OF CALIFORNIA

Bioabsorbable polymeric implants and a method of using the same to create occlusions

A new embolic agent, bioabsorbable polymeric material (BPM) is incorporated to a Guglielmi detachable coil (GDC) to improve long-term anatomic results in the endovascular treatment of intracranial aneurysms. The embolic agent, comprised at least in part of at least one biocompatible and bioabsorbable polymer and growth factors, is carried by hybrid bioactive coils and is used to accelerate histopathologic transformation of unorganized clot into fibrous connective tissue in experimental aneurysms. An endovascular cellular manipulation and inflammatory response are elicited from implantation in a vascular compartment or any intraluminal location. Thrombogenicity of the biocompatible and bioabsorbable polymer is controlled by the composition of the polymer. The coil further is comprised at least in part of a growth factor or more particularly a vascular endothelial growth factor, a basic fibroblast growth factor or other growth factors. The biocompatible and bioabsorbable polymer is in the illustrated embodiment at least one polymer selected from the group consisting of polyglycolic acid, poly~glycolic acid/poly-L-lactic acid copolymers, polycaprolactive, polyhydroxybutyrate/hydroxyvalerate copolymers, poly-L-lactide. Polydioxanone, polycarbonates, and polyanhydrides.
Owner:RGT UNIV OF CALIFORNIA

Bioabsorbable polymeric implants and a method of using the same to create occlusions

InactiveUS20060058835A1Peptide/protein ingredientsDilatorsVascular compartmentPoly-L-lactide
A new embolic agent, bioabsorbable polymeric material (BPM) is incorporated to a Guglielmi detachable coil (GDC) to improve long-term anatomic results in the endovascular treatment of intracranial aneurysms. The embolic agent, comprised at least in part of at least one biocompatible and bioabsorbable polymer and growth factors, is carried by hybrid bioactive coils and is used to accelerate histopathologic transformation of unorganized clot into fibrous connective tissue in experimental aneurysms. An endovascular cellular manipulation and inflammatory response are elicited from implantation in a vascular compartment or any intraluminal location. Thrombogenicity of the biocompatible and bioabsorbable polymer is controlled by the composition of the polymer. The coil further is comprised at least in part of a growth factor or more particularly a vascular endothelial growth factor, a basic fibroblast growth factor or other growth factors. The biocompatible and bioabsorbable polymer is in the illustrated embodiment at least one polymer selected from the group consisting of polyglycolic acid, poly˜glycolic acid / poly-L-lactic acid copolymers, polycaprolactive, polyhydroxybutyrate / hydroxyvalerate copolymers, poly-L-lactide. Polydioxanone, polycarbonates, and polyanhydrides.
Owner:RGT UNIV OF CALIFORNIA

Method for preparing biodegradable filling materials, product prepared by aid of method and application of product

The invention relates to a method for preparing biodegradable filling materials, a product prepared by the aid of the method and application of the product. The method mainly includes steps of (1), mixing matrix materials and dispersion-phase materials according to a mass ratio of 10:0-6:4 with one another and dissolving the matrix materials and the dispersion-phase materials in organic solvents to obtain high-polymer organic solvents; (2), treating the high-polymer organic solvents by the aid of a mechanical process or an emulsification process to obtain a micro-sphere. The matrix materials comprise polydioxanone; the dispersion-phase materials comprise a type of or a plurality of types of poly-L-lactic acid, polycaprolactone, polylactic acid and polyglycolic acid. The method, the product and the application have the advantages that the method is easy to implement, low in cost and good in repeatability, the product comprises tiny and stable particles, and the micro-sphere prepared by the aid of the method has similar and controllable particle sizes, is good in filling performance and tissue compatibility and is safe and degradable; the product can be degraded slowly, the degradation time can be regulated and controlled according to selection of the types and the adding proportions of the dispersion-phase materials; the micro-sphere can be used for preparing freeze-dried powder preparations and gel preparations, and the product is convenient to transport, store and clinically use.
Owner:重庆瑞凡德生物科技有限公司

A kind of preparation method of biodegradable filling material and its product and application

The invention relates to a method for preparing biodegradable filling materials, a product prepared by the aid of the method and application of the product. The method mainly includes steps of (1), mixing matrix materials and dispersion-phase materials according to a mass ratio of 10:0-6:4 with one another and dissolving the matrix materials and the dispersion-phase materials in organic solvents to obtain high-polymer organic solvents; (2), treating the high-polymer organic solvents by the aid of a mechanical process or an emulsification process to obtain a micro-sphere. The matrix materials comprise polydioxanone; the dispersion-phase materials comprise a type of or a plurality of types of poly-L-lactic acid, polycaprolactone, polylactic acid and polyglycolic acid. The method, the product and the application have the advantages that the method is easy to implement, low in cost and good in repeatability, the product comprises tiny and stable particles, and the micro-sphere prepared by the aid of the method has similar and controllable particle sizes, is good in filling performance and tissue compatibility and is safe and degradable; the product can be degraded slowly, the degradation time can be regulated and controlled according to selection of the types and the adding proportions of the dispersion-phase materials; the micro-sphere can be used for preparing freeze-dried powder preparations and gel preparations, and the product is convenient to transport, store and clinically use.
Owner:重庆瑞凡德生物科技有限公司

Nano-hydroxyapatite-modified polyurethane urea bone repair material and preparation method thereof

The invention discloses a nano-hydroxyapatite-modified polyurethane urea bone repair material and a preparation method thereof. The preparation method comprises the following steps: adding nano-hydroxyapatite into a dihydroxy-terminal polydioxanone solution, uniformly dispersing and then heating; adding a diisocyanate chain extender containing a ureido structure and carrying out chain extension reaction to obtain a dual-terminal isocyanate prepolymer; carrying out self-crosslinking reaction on the dual-terminal isocyanate prepolymer and polyatomic alcohol, removing a solvent and carrying out vacuum drying at normal temperature to obtain the nano-hydroxyapatite-modified polyurethane urea bone repair material, wherein the chain extension reaction is a chemical reaction that hydroxyl reacts with isocyanato to generate a mephenesin carbamate group. According to the method, a polyurethane-urea high polymer material is integrated with nano-hydroxyapatite with high biocompatibility to obtaina framework material with high porosity and proper aperture size; and the obtained bone repair material has the advantages of controllable degradation performance, good repair effect, high mechanicalproperty, high biocompatibility, absorbable degradation product and the like.
Owner:济南羽时信息科技有限公司

Periodically degrading type tear drainage rebuilding system

The invention relates to a tear drainage reconstruction system that can be regularly degraded. The reconstruction system is made by adopting polydioxanone (PDO) that is a degradable polymeric biomaterial. The system comprises an upper lacrimal duct part, a lower lacrimal dust part, a main lacrimal duct, a concave dacryocyst part and a nasolacrimal duct part. The system has good flexibility, certain elasticity, extensibility, breaking strength and compression strength performance and is a lamella micro-porous tubular structure that integrates stable nasolacrimal duct supporting function, 'tears pump' function, dacryocyst drainage function, 'drug control-release' function, the function of accelerating the fade-away of chronic inflammation of a lacrimal duct and the repairing function of mucous membrane injury of the lacrimal duct together. The reconstruction system has the advantages that an implanting method is a simple and convenient, the fixation in the lacrimal duct is the stable and reliable and the iatrogenic lacrimal duct injury can not appear, the regular degradation can be realized without secondary take-out and the reconstruction system is suitable for various lacrimal duct obstruction diseases and has high curative ratio of the lacrimal duct obstruction, especially, the reconstruction system has the stable and reliable medium-to-long term effect. The tears drainage reconstruction system currently is the only perfect material for high-degree lacrimal duct reconstruction that combines the physiological drainage of the tears with the pathological mechanism of lacrimal injury repair.
Owner:吴文灿 +1

Absorbable and knotting-free surgical suture capable of continuously resisting infection and used for thoracic surgery department

The invention provides an absorbable and knotting-free surgical suture capable of continuously resisting infection and used for thoracic surgery department. The absorbable and knotting-free surgical suture is composed of a PPDO (polydioxanone) fiber core located at the inner part, a compound drug-loading layer located in a middle layer and a collagen layer located on the outermost layer, wherein aplurality of tapered lug bosses are uniformly distributed on the compound drug-loading layer; the tapered lug bosses and the compound drug-loading layer are integrally molded; each tapered lug boss is composed of an inclined plane and a tabletop; the compound drug-loading layer is prepared from konjac glucomannan, quatemary ammonium salt chitosan, hyaluronic acid and genipin. The surgical sutureprepared by the invention does not need to be knotted in a surgery suturing process, can smoothly pass through muscle, does not easily slip off and has good biocompatibility; the absorbable and knotting-free surgical suture has a slow-release and antibacterial effect; after the absorbable and knotting-free surgical suture is degraded in a body, a product is discharged out of the body through metabolism, so that the absorbable and knotting-free surgical suture has no dangers and no toxic side effect.
Owner:王传强
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products